Thromb Haemost 2018; 118(09): 1679-1680
DOI: 10.1055/s-0038-1668582
Erratum
Georg Thieme Verlag KG Stuttgart · New York

Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale

James D. Douketis
1  Department of Medicine, McMaster University, Hamilton, Canada
,
Alex C. Spyropoulos
2  Department of Medicine, Hofstra Northwell School of Medicine, Northwell Health at Lenox Hill Hospital, New York, New York, United States
,
Julia M. Anderson
3  Department of Medicine, University of Edinburgh, Edinburgh, United Kingdom
,
Donald M. Arnold
1  Department of Medicine, McMaster University, Hamilton, Canada
,
Shannon M. Bates
1  Department of Medicine, McMaster University, Hamilton, Canada
,
Mark Blostein
4  Department of Medicine, McGill University, Montreal, Canada
,
Marc Carrier
5  Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada
,
Joseph A. Caprini
6  NorthShore University Health Systems, Evanston, Illinois, United States
,
Nathan P. Clark
7  Department of Pharmacy, Kaiser Permanente Colorado, Aurora, Colorado, United States
,
Michiel Coppens
8  Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
,
Francesco Dentali
9  Department of Medicine and Surgery, Insubria University, Varese, Italy
,
Joanne Duncan
1  Department of Medicine, McMaster University, Hamilton, Canada
,
Peter L. Gross
1  Department of Medicine, McMaster University, Hamilton, Canada
,
Jeannine Kassis
10  Department of Medicine, Université de Montréal, Montreal, Canada
,
Stephen Kowalski
11  Department of Anesthesiology, University of Manitoba, Winnipeg, Canada
,
Agnes Y. Lee
12  Department of Medicine, University of British Columbia, Vancouver, Canada
,
Gregoire Le Gal
13  L'Institut du Savoir Montfort, L'Hopital Monfort, Ottawa, Ontario, Canada
,
Geneviève Le Templier
14  Department of Internal Medicine, Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada
,
Na Li
1  Department of Medicine, McMaster University, Hamilton, Canada
,
Elizabeth MacKay
15  Department of Medicine, University of Calgary, Calgary, Canada
,
Vinay Shah
16  Department of Medicine, Henry Ford Hospital, Detroit, Michigan, United States
,
Sudeep Shivakumar
17  Department of Medicine, Dalhousie University, Halifax, Canada
,
Susan Solymoss
4  Department of Medicine, McGill University, Montreal, Canada
,
Frederick A. Spencer
1  Department of Medicine, McMaster University, Hamilton, Canada
,
Summer Syed
18  Department of Anesthesiology, Hamilton Health Sciences, McMaster University, Hamilton, Canada
,
Alfonso J. Tafur
6  NorthShore University Health Systems, Evanston, Illinois, United States
,
Thomas Vanassche
19  Department of Cardiovascular Sciences, Universitaire Ziekenhuizen Leuven, Leuven, Belgium
,
Thomas Thiele
20  Institute for Immunology and Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany
,
Cynthia Wu
21  Department of Medicine, University of Alberta, Edmonton, Canada
,
Erik Yeo
22  Department of Medicine, University of Toronto, Toronto, Canada
,
Sam Schulman
1  Department of Medicine, McMaster University, Hamilton, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
14 September 2018 (online)

In the Original Article by Douketis et al. “The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale” (Thromb Haemost 2017;117:2415–2424; DOI: 10.1160/TH17-08-0553), the authors have identified two errors that they wish to correct:

First, on page 2419, second paragraph, Clinical Outcomes subheading, the authors state that, “The primary clinical outcomes are arterial thromboembolism, comprising stroke (ischemic or haemorrhagic), systemic embolism or transient ischemic attack and major bleeding.” The inclusion of “haemorrhagic” stroke is incorrect as only ischemic strokes are included in their definition of an arterial thromboembolism outcome.

The definitions of study outcomes are correctly indicated in Appendix A (pg. 2424) of the paper, where the authors state: “The second primary outcome is arterial thromboembolism, comprising (1) ischemic stroke , defined as any new focal neurologic deficit that persists for >24 hours or any new focal neurologic deficit of any duration that occurs with evidence of acute infarction on computed tomography (CT) or magnetic resonance imaging (MRI) of the brain; (2) systemic embolism, defined as symptomatic embolism to upper or lower extremity or abdominal organ, confirmed intraoperatively or by objective imaging studies (e.g. CT angiography) and (3) transient ischemic attack, defined as symptomatic focal neurologic deficit (lasting typically <1 hour) that occurs with no evidence of acute infarction on CT/MRI of the brain.”

Second, the depiction of the pre-procedure interruption interval for dabigatran-treated patients with a CrCl <50 mL/min is incorrect in Figure 1 (pg. 2418) of the paper, as the arrow should extend so it reflects 2 days off treatment (i.e., day -2 and day -1). The incorrect (currently published) version is shown below, with incorrect area shaded in red:

Zoom Image

The corrected version should appear as follows, with extension of the arrow by one cell to the right the row pertaining to dabigatran, CrCl <50 mL/min:

Zoom Image

The authors apologize for these errors and would be happy to address any questions or clarifications regarding these corrections.